Should patients with chronic hepatitis c who have normal alt levels be treated?
- 1 February 2001
- journal article
- case report
- Published by Springer Nature in Current Gastroenterology Reports
- Vol. 3 (1) , 49-53
- https://doi.org/10.1007/s11894-001-0040-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Effects of 1-Year Interferon-Alpha 2a Treatment in Patients with Chronic Hepatitis C and Persistently Normal Transaminase ActivityScandinavian Journal of Gastroenterology, 2000
- Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the southwestern United StatesHepatology, 1999
- Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: A pilot randomized controlled studyHepatology, 1998
- Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activityHepatology, 1998
- Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levelsHepatology, 1997
- Therapy of hepatitis C: Patients with normal aminotransferase levelsHepatology, 1997
- Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levelsHepatology, 1997
- Virological response to interferon treatment in hepatitis C virus carriers with normal aminotransferase levels and chronic hepatitisHepatology, 1997
- Interferon-α therapy for individuals with normal serum alanine aminotransferase levels before treatmentJournal of Gastroenterology and Hepatology, 1997
- Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon α2b therapyJournal of Hepatology, 1995